drug
daxibotulinumtoxinA
Marketedupdated 3mo agoby Revance Therapeutics Inc
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying daxibotulinumtoxinA
- phase4Effects of DaxibotulinumtoxinA for Blepharospasm and Hemifacial Spasm
- phase2Phase 2a Study of DaxibotulinumtoxinA-lanm for Injection in Dynamic Forehead Lines and Glabellar Lines
- —An Open Label, Study of DaxibotulinumtoxinA for Migraine Prevention
- phase2Efficacy and Safety of DaxibotulinumtoxinA (DAXI) for Injection for Treatment of Upper Facial Lines
- phase2Efficacy and Safety of Increasing Doses of DaxibotulinumtoxinA for Injection (DAXI for Injection) in the Treatment of Moderate or Severe Lateral Canthal Lines
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 14m ago
Found something off?
comments(0)
5-min edit window · permanent after that